It had earlier cut its full-year sales and profit forecasts
These results are estimates based on general formulas and are not a substitute for professional medical advice
But their high cost, months-long waitlists, and potential side effects have many people seeking natural alternatives
Understanding Self-Pay Pricing for GLP-1 Medications Not every insurance plan covers GLP-1s for weight loss, and some patients prefer to stay outside of insurance altogether
Mounjaro was approved by the FDA for type 2 diabetes treatment in 2022
Several DPP-4 inhibitors with distinct structures have been approved for clinical use, including sitagliptin, alogliptin, linagliptin, gemigliptin, anagliptin, and teneligliptin (22) (Appendix 1 in Supplementary File)